Comparative efficacy of four commercially available heartworm preventive products against the MP3 laboratory strain of Dirofilaria immitis

Veterinary Parasitology

Volumn 176, Issue 2-3, 2011, Pages 189-194

  Blagburn, B L ^a   Dillon, A R ^a   Arther, R G ^b   Butler, J M ^a   Newton, J C ^a  

^a AUBURN UNIVERSITY   (United States)

^b BAYER CORPORATION   (United States)

Author keywords

D. immitis; Efficacy; Heartworm; MP3 isolate

Indexed keywords

ADVANTAGE MULTI; ANTHELMINTIC AGENT; HEARTGARD PLUS CHEWABLES; IMIDACLOPRID; IMIDACLOPRID PLUS MOXIDECTIN; INTERCEPTOR; IVERMECTIN PLUS PYRANTEL EMBONATE; MILBEMYCIN; MOXIDECTIN; PARASITE ANTIGEN; REVOLUTION; SELAMECTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; COMPARATIVE STUDY; CONTROLLED STUDY; DIROFILARIA IMMITIS; DIROFILARIASIS; DOG DISEASE; DRUG EFFICACY; FEMALE; HUMAN; MALE; NONHUMAN; PARASITE LOAD; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; WEIGHT REDUCTION;

ANIMALS; ANTHELMINTICS; DIROFILARIA IMMITIS; DIROFILARIASIS; DOG DISEASES; DOGS; FEMALE; MALE;

ANIMALIA; CANIS FAMILIARIS; DIROFILARIA IMMITIS;

EID: 79952038639     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2010.12.049     Document Type: Article

References (11)

1. Arther R.G., Bowman D.D., Slone R.L., Travis L.E. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasitol. Res. 2005, 97(suppl. 1):76-80.
2. Beddies G. Serum pharmacokinetics of imidacloprid 10% w/v/moxidectin w/v 2.5% spot-on in dogs applied once per month for three consecutive monthly intervals. FOI Summary. Advantage Multi for Dogs 2006, NADA-141-251.
3. Blagburn B., Dillon R., Prichard R., Geary T., Mount J., Land T., Butler J., Bourguinat C. Characterization of heartworm prevention failures in the central United States. Proc. 13th Triennial Heartworm Symposium 2010, 27.
4. Bowman D.D., Atkins C.E. Heartworm biology, treatment, and control. Vet. Clin. North Am./Small Anim. Pract. 2009, 39:1127-1158.
5. Bourguinat C., Keller K., Schenker R., Blagburn B., Prichard R.K., Geary T.G. Investigation of genetic changes in Dirofilaria immitis after the use of macrocyclic lactone heartworm preventives. Proc. 13th Triennial Heartworm Symposium 2010, 28.
6. Grieve R.B., Frank G.R., Stewart V.A., Parsons J.C., Belasco J.C., Hepler D.I. Chemoprophylactic effects of milbemycin oxime against larvae of Dirofilaria immitis during prepatent development. Am. J. Vet. Res. 1991, 52:2040-2042.
7. Hampshire V.A. Evaluation of efficacy of heartworm preventive products at the FDA. Vet. Parasitol. 2005, 133:191-195.
8. McCall J.W., Genchi C., Kramer L.H., Guerrero J., Venco L. Heartworm disease in animals and humans. Adv. Parasitol. 2007, 66:193-285.
9. Patton S., Odoi A., Rohrbach B.W. Survey of heartworm prevention practices among dog owners and trainers in North America. Proc. 13th Triennial Heartworm Symposium 2010, 26.
10. Prichard R.K. Is anthelmintic resistance a concern for heartworm control? What can we learn from human filariasis control programs. Vet. Parasitol. 2005, 133:243-253.
11. Rohrbach B.W., Odoi A., Rohrbach B.W. Survey to identify risk factors for failure to prevent heartworm infection in dogs. Proc. 13th Triennial Heartworm Symposium 2010, 26.